To this aim, we regressed the observed rates of TFs on the mutation status of ATRX and DAXX, telomere content, point mutations and structural variants in the TERT promoter, expression values of TERT and TERRA, and a binary category indicating the ALT status of each tumour predicted using two previously published classifiers21,24. The gene discussed is ATRX; the disease is neoplasm.